Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Cardiovascular risk factors are independently associated with COVID-19 mortality: a prospective cohort study

View ORCID ProfileDidier Collard, View ORCID ProfileNick S. Nurmohamed, View ORCID ProfileYannick Kaiser, View ORCID ProfileLaurens F. Reeskamp, View ORCID ProfileTom Dormans, Hazra Moeniralam, Suat Simsek, Renée A. Douma, Annet Eerens, Auke C. Reidinga, View ORCID ProfilePaul Elbers, View ORCID ProfileMartijn Beudel, View ORCID ProfileLiffert Vogt, View ORCID ProfileErik S.G. Stroes, View ORCID ProfileBert-Jan H. van den Born
doi: https://doi.org/10.1101/2020.10.01.20205229
Didier Collard
1Amsterdam UMC, University of Amsterdam, Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Didier Collard
Nick S. Nurmohamed
1Amsterdam UMC, University of Amsterdam, Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands
2Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nick S. Nurmohamed
Yannick Kaiser
1Amsterdam UMC, University of Amsterdam, Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yannick Kaiser
Laurens F. Reeskamp
1Amsterdam UMC, University of Amsterdam, Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laurens F. Reeskamp
Tom Dormans
3Zuyderland Medisch Centrum, Department of Intensive Care, Sittard-Geleen, the Netherlands
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tom Dormans
Hazra Moeniralam
4St. Antonius Hospital, Department of Internal Medicine, Nieuwegein, the Netherlands
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suat Simsek
5Northwest Clinics, Department of Internal Medicine, Alkmaar, The Netherlands
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Renée A. Douma
6Flevohospital, Department of Internal Medicine, Almere, The Netherlands
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annet Eerens
7Treant Healthcare Group, Department of Oncology, Hoogeveen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Auke C. Reidinga
8Martini Hospital, Intensive Care Unit, Groningen, The Netherlands
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Elbers
9Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Intensive Care, Amsterdam Amsterdam, the Netherlands
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paul Elbers
Martijn Beudel
10Amsterdam UMC, University of Amsterdam, Department of Neurology, Amsterdam Neuroscience Institute, Amsterdam, the Netherlands
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martijn Beudel
Liffert Vogt
11Amsterdam UMC, University of Amsterdam, Department of Nephrology, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Liffert Vogt
Erik S.G. Stroes
1Amsterdam UMC, University of Amsterdam, Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erik S.G. Stroes
Bert-Jan H. van den Born
1Amsterdam UMC, University of Amsterdam, Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands
12Amsterdam UMC, University of Amsterdam, Department of Public Health, Amsterdam, the Netherlands
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bert-Jan H. van den Born
  • For correspondence: b.j.vandenborn@amsterdamumc.nl
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives Recent reports suggest a high prevalence of hypertension and diabetes in COVID-19 patients, but the role of cardiovascular disease (CVD) risk factors in the clinical course of COVID-19 is unknown. We evaluated the time-to-event relationship between hypertension, dyslipidemia, diabetes, and COVID-19 outcomes.

Design We analyzed data from the prospective Dutch COVID-PREDICT cohort, an ongoing prospective study of patients admitted for COVID-19 infection.

Setting Patients from 8 participating hospitals, including two university hospitals from the COVID-PREDICT cohort were included.

Participants Admitted, adult patients with a positive COVID-19 polymerase chain reaction (PCR) or high suspicion based on CT-imaging of the thorax. Patients were followed for major outcomes during hospitalization. CVD risk factors were established via home medication lists and divided in antihypertensives, lipid lowering therapy, and antidiabetics.

Primary and secondary outcomes measures The primary outcome was mortality during the first 21 days following admission, secondary outcomes consisted of ICU-admission and ICU-mortality. Kaplan-Meier and Cox-regression analyses were used to determine the association with CVD risk factors.

Results We included 1604 patients with a mean age of 66±15 of whom 60.5% were men. Antihypertensives, lipid lowering therapy, and antidiabetics were used by 45%, 34.7%, and 22.1% of patients. After adjustment for age and sex, the presence of ≥2 risk factors was associated with increased mortality risk (HR 1.52, 95%CI 1.15-2.02), but not with ICU-admission. Moreover, the use of ≥2 antidiabetics and ≥2 antihypertensives was associated with mortality independent of age and sex with HRs of respectively 2.09 (95%CI 1.55-2.80) and 1.46 (95%CI 1.11-1.91).

Conclusions The accumulation of hypertension, dyslipidemia and diabetes leads to a stepwise increased risk for short-term mortality in hospitalized COVID-19 patients independent of age and sex. Further studies investigating how these risk factors disproportionately affect COVID-19 patients are warranted.

Strengths and limitations of this study

  • While previous data reported a high prevalence of CVD risk factors in COVID-19 patients, this study investigated whether diabetes, dyslipidemia and hypertension predict adverse outcomes.

  • This study is limited by the use of medication as surrogate for cardiovascular risk factors

  • The causality of the investigated risk factors remains to be addressed in future studies.

Competing Interest Statement

N.S.N. and L.F.R. are co-founders of Lipid Tools. E.S.G.S. reports personal fees from Amgen, personal fees from Sanofi-Regeneron, personal fees from Esperion, grants from Athera, outside the submitted work.

Funding Statement

DC is supported by a ZonMW grant (project number: 10430022010002).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The institutional review board of the Amsterdam UMC, Amsterdam, the Netherlands

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data that support the findings of this study are available from the corresponding author, upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted October 02, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Cardiovascular risk factors are independently associated with COVID-19 mortality: a prospective cohort study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Cardiovascular risk factors are independently associated with COVID-19 mortality: a prospective cohort study
Didier Collard, Nick S. Nurmohamed, Yannick Kaiser, Laurens F. Reeskamp, Tom Dormans, Hazra Moeniralam, Suat Simsek, Renée A. Douma, Annet Eerens, Auke C. Reidinga, Paul Elbers, Martijn Beudel, Liffert Vogt, Erik S.G. Stroes, Bert-Jan H. van den Born
medRxiv 2020.10.01.20205229; doi: https://doi.org/10.1101/2020.10.01.20205229
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Cardiovascular risk factors are independently associated with COVID-19 mortality: a prospective cohort study
Didier Collard, Nick S. Nurmohamed, Yannick Kaiser, Laurens F. Reeskamp, Tom Dormans, Hazra Moeniralam, Suat Simsek, Renée A. Douma, Annet Eerens, Auke C. Reidinga, Paul Elbers, Martijn Beudel, Liffert Vogt, Erik S.G. Stroes, Bert-Jan H. van den Born
medRxiv 2020.10.01.20205229; doi: https://doi.org/10.1101/2020.10.01.20205229

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1747)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (653)
  • Epidemiology (10779)
  • Forensic Medicine (8)
  • Gastroenterology (583)
  • Genetic and Genomic Medicine (2933)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1918)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12496)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (321)
  • Neurology (2780)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (553)
  • Occupational and Environmental Health (597)
  • Oncology (1454)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (379)
  • Pediatrics (864)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2630)
  • Public and Global Health (5338)
  • Radiology and Imaging (1002)
  • Rehabilitation Medicine and Physical Therapy (594)
  • Respiratory Medicine (722)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)